Delphinus Medical Technologies Inc. announced that it has secured a venture round of $39.5 million, the single largest amount ever raised for a healthcare imaging company in the Midwest. It is also the largest amount for a medical device company in Michigan.
Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a new pilot study. The study was described at the International Contrast Ultrasound Society (ICUS) annual conference in Chicago.
Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
The transition from film to flat panel has dramatically improved the efficiency of portable X-ray units. Transmitting ...
September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Ninety-six percent of clinics and hospitals in the United States that have purchased used or refurbished medical equipment have had neutral-to-positive experiences with the purchase, according to a new survey.
More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center.
SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement Algorithm (SIMA) software from DataSpeaks. SRI will integrate SIMA into the development of a secure enterprise system for clinical decision-making.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Varian Medical Systems is collaborating with two leading Cape Town universities to launch Africa's first 'Access to Care' program, designed to train cancer caregivers in delivering advanced conformal radiotherapy treatments.
When 64-slice computed tomography (CT) systems were introduced nearly a decade ago, they were purchased in large numbers ...
In many ways, medical imaging is the backbone of the entire healthcare industry. Medical professionals can only treat ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Brainlab announced that its Automatic Brain Metastases Planning software has been used for the first time in the United States at Jefferson Hospital for Neuroscience in Philadelphia.
Plan optimization and dose calculation for complex VMAT plans are computationally challenging tasks. Depending on the ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Computed tomography (CT) has enjoyed a place of prominence in medical imaging since its creation in the 1970s. The ...
During the recent American Association of Physicists in Medicine (AAPM) conference in Anaheim, Calif., I had the ...
The heady days of computed tomography (CT) — when 64-slice scanners drove sales to an all-time high — seems like ancient ...
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing installed base of competing systems. The premier European comprehensive cancer center started its radiotherapy program in 2013.
TRU-Vu Monitors has launched a new line of 24-inch HD surgical LCD monitors and touch screens.
Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don't have the mutations. But a new study by the University of California Los Angeles (UCLA) faculty questions the value of screening for the genetic mutations in the general population — including those who do not have cancer or have no family history of the disease — because of the high cost.